Search

everythinglearnresearchcommunity

for

Search:↓

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

Protein tyrosine kinases are key in male pattern baldness, affecting skin structure, hair growth, and immune responses.

Researchers mapped and categorized specific keratin-associated protein genes on human chromosome 21q22.1.

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

The 3D structure of a key hair protein was modeled, revealing specific helical structures and stabilization features.

Platycladus orientalis leaf extract helps hair grow by activating certain proteins.

Skin cells and immune cells change in a skin condition called hidradenitis suppurativa, and a certain treatment can improve these changes.

The conclusion is that healthcare professionals should report adverse drug reactions to improve medication safety and patient care.

Young female Australian fur seals are losing hair due to low tyrosine and zinc levels and high pollution exposure.

Polymeric nanoparticles show promise for treating skin diseases.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Scientists discovered a unique hair protein, KAP24.1, with a special structure, found only in the upper part of hair cuticles.

Sheep have a unique gene, KAP8-2, that humans don't have, which may affect wool properties.

A woman's hair turned white after taking a cancer drug called dasatinib.

A woman's hair turned gray and fell out after starting a cancer drug called imatinib mesylate.

An 84-year-old man developed a rare scalp condition from a cancer drug but continued treatment as it was otherwise well tolerated.

Nilotinib can cause generalized keratosis pilaris.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

Some hair protein genes evolved early and were adapted for use in hair follicles.

A man's bald spot grew hair after starting cancer treatment with gefitinib.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

The gp130 receptor helps in tissue regeneration and disease progression, and manipulating it could improve healing and prevent disease.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

Androgens increase growth factors in skin cells, which may lead to acne.

MicroRNAs are crucial in controlling cell signaling, affecting cancer and tissue regeneration.

Different hair types in mammals are linked to variations in specific protein genes, with changes influenced by their living environments.

Gab1 protein is crucial for hair growth and stem cell renewal, and Mapk signaling helps maintain these processes.

A cancer patient's eyelashes grew excessively without other common side effects after taking the cancer drug erlotinib.